Multicenter Prospective Observational Study Evaluating the Management of Heart Failure (ADAPTATION-HF)

AstraZeneca

Status: Completed

Conditions: Heart Failure

Treatments: Other: Questionnaies

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT05180370

K-J019

Details and patient eligibility

About

ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study.

Full description

ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study. Data entry staff who will be assigned to the centers for 2 weeks will apply a questionnaire consisting of different questions to the patients referred to them by clinicians with the diagnosis of HF. In addition, Pittsburg Sleep Quality Index will be applied to all cases. In addition, clinical features of HF from the current file of the cases (NYHA, comorbid conditions, comorbid diseases, blood pressure, heart rate, last drugs used, latest biochemistry (BNP/NTproBNP if available), hematology test results, most recent ECG , most recent echocardiography, coronary angiography report, if available) will be recorded. No additional examination/procedure will be performed for the study, only the data of the examinations requested by the clinician in routine clinical practice will be entered. A total of 500 patients from 10 centers will be included in this study over a six-month period.

Enrollment: 500 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatient or inpatient diagnosed with Heart Failure at least 6 months ago
• Male or female patient aged 18 and over
• Signed written informed consent form

Exclusion criteria

• newly diagnosed heart failure
• CRY requiring dialysis
• Serious liver and lung disease
• LVAD/heart transplantation
• HF due to possible temporary cause (myocarditis, peripartum CMP in the first 6 months, takotsubo etc.)

Trial design

500 participants in 1 patient group

Outpatient or inpatient diagnosed with Heart Failure at least 6 months ago

Description:

ADAPTATION HF is a prospective, observational, cross-sectional, multicenter, survey-based study. Patients who applied to the cardiology outpatient clinic with a preliminary diagnosis of HF or were hospitalized for HF and had a diagnosis of HF for at least 6 months will be included in the study.

Treatment:

Other: Questionnaies